IntraBio

This page is dedicated to news and information about IntraBio’s therapies for use in Niemann-Pick Disease Type C (NPC).
Information is released as it becomes available.

CLINICALTRIALS.GOV

ABOUT INTRABIO GLOSSARY OF TERMS

IntraBio Clinical Trial Authorization Application Approved by the MHRA for the Treatment of NPC

.
CLICK HERE FOR COMPLETE ANNOUNCEMENT

03/11/2019 jjb

IntraBio Investigational New Drug Application Approved by the FDA for the Treatment of NPC

.
CLICK HERE FOR COMPLETE ANNOUNCEMENT

02/13/2019 jjb

IntraBio Receives Niemann-Pick Disease Orphan Drug Designation from the FDA for IB1000 Series

.
CLICK HERE FOR COMPLETE ANNOUNCEMENT

11/26/2018 jjb

The National Niemann-Pick Disease Foundation (NNPDF) does not engage in the practice of medicine. It is not a medical authority nor does it claim to have medical knowledge. This site is an educational service of the National Niemann-Pick Disease Foundation and is not meant to provide diagnostic or treatment advice. Information contained or suggested on this Web site does not constitute medical advice. For all information related to care, medication or treatment, the NNPDF recommends consulting a physician to determine if information presented is applicable. Please review these additional cautions about medical information provided on the Internet.

This Web site is a service of the National Niemann-Pick Disease Foundation's Family Services Program, made possible by the financial support of our member families and other generous donors and grantors. This site receives no government funding, nor does it host or receive funding from advertising or from the display of commercial content.

The National Niemann-Pick Disease Foundation is a 501(c)(3) organization. Your donations are fully tax-deductible.

IntraBio

IntraBio Clinical Trial Authorization Application Approved by the MHRA for the Treatment of NPC

03/11/2019 jjb

IntraBio Investigational New Drug Application Approved by the FDA for the Treatment of NPC

02/13/2019 jjb

IntraBio Receives Niemann-Pick Disease Orphan Drug Designation from the FDA for IB1000 Series

11/26/2018 jjb

Share this!